View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

El Pollo Loco Brings Fan-Favorite Stuffed Quesadillas Back with New Se...

El Pollo Loco Brings Fan-Favorite Stuffed Quesadillas Back with New Seasonal Flavors Satisfy Your Cravings with Our Three Delicious Stuffed Quesadillas—They Make The Ultimate Grab-and-Go Meal for Those Who Want Convenience without Sacrificing Flavor COSTA MESA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- El Pollo Loco, Inc. ("El Pollo Loco" or "Company") (Nasdaq: LOCO), the nation's leading restaurant chain specializing in fire-grilled chicken, is bringing back two fan-favorite seasonal Stuffed Quesadilla flavors to join the menu for a limited time, alongside the permanent Chicken Avocado ...

 PRESS RELEASE

Victoria’s Secret & Co. Invites You to Listen to the First Quarter 202...

Victoria’s Secret & Co. Invites You to Listen to the First Quarter 2024 Earnings Call Webcast REYNOLDSBURG, Ohio, May 15, 2024 (GLOBE NEWSWIRE) -- In conjunction with the Victoria’s Secret & Co. (NYSE: VSCO) first quarter 2024 earnings release, which will cross the wire after market close on Wednesday, June 5th, you are invited to listen to a live webcast of the conference call on Thursday, June 6th at 8:00 a.m. ET with Victoria’s Secret & Co. executives. What:Victoria’s Secret & Co. First Quarter 2024 Earnings Conference Call Webcast  When:8:00 a.m. ET on Thursday, June 6th, 2024  Where:...

Crocs Inc: 1 director

A director at Crocs Inc sold 10,174 shares at 140.316USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect ...

Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsychiatric disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia, and other central nervous system (CNS) diseases, today announced that Christopher U. Missling, PhD, President and Chief Executi...

Matt Quigley ... (+2)
  • Matt Quigley
  • Tom Nikic
Wedbush Research
  • Wedbush Research
TPX TEMPUR SEALY INTERNATIONAL INC
GEO GEO GROUP INC. (THE)
2454 MEDIATEK INC.
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
TSLA TESLA INC
TSCO TRACTOR SUPPLY COMPANY
TRIP TRIPADVISOR INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SBRA SABRA HEALTH CARE REIT INC.
QCOM QUALCOMM INC
PZZA PAPA JOHN'S INTERNATIONAL INC.
PSTG PURE STORAGE INC. CLASS A
OHI OMEGA HEALTHCARE INVESTORS INC.
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
NHI NATIONAL HEALTH INVESTORS INC.
MU MICRON TECHNOLOGY INC.
LTC LTC PROPERTIES INC.
LOW LOWE'S COMPANIES INC.
JCOM J2 GLOBAL INC.
INTC INTEL CORPORATION
HD HOME DEPOT INC.
GOOGL ALPHABET INC. CLASS A
35G GENPACT LIMITED
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CXW CORECIVIC INC.
CRM SALESFORCE.COM INC.
CHUY CHUY'S HOLDINGS INC.
AXTI AXT INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
FND FLOOR & DECOR HOLDINGS INC. CLASS A
ANAB ANAPTYSBIO INC.
OKTA OKTA INC. CLASS A
SNBR SLEEP NUMBER CORPORATION
MDB MONGODB INC. CLASS A
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
AVGO BROADCOM INC.
PRPL PURPLE INNOVATION
LEGH LEGACY HOUSING CORP
CRNC CERENCE
SMCI SUPER MICRO COMPUTER
U INC.
PLTR UNITY SOFTWARE
VOR PALANTIR TECHNOLOGIES
PLTK VOR BIOPHARMA
SNOW PLAYTIKA HOLDING
RBLX SNOWFLAKE INC. CLASS A
GHLD ROBLOX
MRVL GUILD HOLDINGS
STX MARVELL TECHNOLOGY INC
ALIT SEAGATE TECHNOLOGY HLDGS PLC
UWMC FOLEY TRASIMENE ACQUISITION CORP
ATXS UWM HLDGS CORP
CCSI ASTRIA THERAPEUTICS INC
GFS CONSENSUS CLOUD SOLUTIONS INC
TYRA GLOBALFOUNDRIES INC
SOUN TYRA BIOSCIENCES INC
GETY SOUNDHOUND AI INC
GTBIF GETTY IMAGES HOLDINGS INC
SKLZ GREEN THUMB INDUSTRIES INC.
DNTH SKILLZ INC
DIANTHUS THERAPEUTICS INC
Michael Symington ... (+2)
  • Michael Symington
  • Nick Setyan
 PRESS RELEASE

Victoria’s Secret & Co. Provides First Quarter 2024 Preliminary Result...

Victoria’s Secret & Co. Provides First Quarter 2024 Preliminary Results Sales, adjusted operating income, adjusted EPS at the high end or above guidance Reaffirms fiscal 2024 sales and adjusted operating income guidance REYNOLDSBURG, Ohio, May 09, 2024 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“Victoria’s Secret” or the “Company”) (NYSE: VSCO) today provided preliminary results for the first quarter 2024 ended May 4, 2024. Net sales, adjusted operating income, and adjusted diluted earnings per share for the first quarter are at or above previously issued guidance as highlight...

 PRESS RELEASE

Chuy’s Holdings, Inc. Announces First Quarter 2024 Financial Results

Chuy’s Holdings, Inc. Announces First Quarter 2024 Financial Results AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Chuy’s Holdings, Inc. (NASDAQ:CHUY) (the "Company") today announced financial results for the first quarter ended March 31, 2024. Highlights for the first quarter ended March 31, 2024 were as follows: Revenue was $110.5 million compared to $112.5 million in the first quarter of 2023. Revenue was negatively impacted by approximately $1.8 million as a result of a one-week calendar shift due to a 53rd week in fiscal 2023.On a fiscal basis, comparable restaurant sales dec...

 PRESS RELEASE

Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Resu...

Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update Company to host a today at 8:30 a.m. Eastern Time NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsychiatric disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia, and other central nervous system (CNS) diseases, today reported financia...

 PRESS RELEASE

The Buckle, Inc. Reports April 2024 Net Sales

KEARNEY, Neb.--(BUSINESS WIRE)-- The Buckle, Inc. (NYSE: BKE) announced today that comparable store net sales, for stores open at least one year, for the 4-week period ended May 4, 2024 decreased 6.0 percent from comparable store net sales for the 4-week period ended May 6, 2023. Net sales for the 4-week fiscal month ended May 4, 2024 decreased 8.1 percent to $79.9 million from net sales of $86.9 million for the prior year 4-week fiscal month ended April 29, 2023. Comparable store net sales for the 13-week first quarter ended May 4, 2024 decreased 9.0 percent from comparable store net sales ...

 PRESS RELEASE

Anika Announces CFO Transition

Anika Announces CFO Transition Steve Griffin Appointed Chief Financial Officer, Effective June 3, 2024 BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it has appointed Steve Griffin as the Company’s Executive Vice President, Chief Financial Officer (“CFO”) and Treasurer, effective June 3, 2024. He succeeds Michael Levitz, who has decided to step down as CFO after almost four years with the company. Mr. Levitz will remain with the Company through December 31, 2024, to ensure a sm...

 PRESS RELEASE

Anika Reports First Quarter 2024 Financial Results

Anika Reports First Quarter 2024 Financial Results Revenue up 7% on growing demand and favorable order timing; On-track for 2024 revenue guidance Cost reduction initiatives complete; On-track to achieve 2024 adjusted EBITDA guidance of $25-30 million, up over 75% at the midpoint BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its first quarter ended March 31, 2024. First Quarter 2024 Financial Summary Revenue in the first quarter of 2024 was $4...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch